home / stock / bioyf / bioyf short
Short Information | BioSyent Inc. (OTCMKTS:BIOYF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 15,158 |
Total Actual Volume | 18,175 |
Short Trends | |
---|---|
Cover Days | 2 |
Short Days | 18 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 758 |
Average Short Percentage | 87.09% |
Is there a BIOYF Short Squeeze or Breakout about to happen?
See the BIOYF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-16-2024 | $7.41 | $7.41 | $7.41 | $7.41 | 100 | 100 | 100% |
07-15-2024 | $7.5 | $7.32 | $7.5 | $7.32 | 570 | 195 | 34.21% |
07-12-2024 | $0 | $7.5 | $0 | $0 | 50 | 50 | 100% |
07-10-2024 | $0 | $7.49 | $0 | $0 | 5 | 5 | 100% |
07-05-2024 | $7.41 | $7.49 | $7.49 | $7.41 | 2,110 | 510 | 24.17% |
07-03-2024 | $0 | $7.49 | $0 | $0 | 200 | 200 | 100% |
07-02-2024 | $0 | $7.49 | $0 | $0 | 27 | 27 | 100% |
06-28-2024 | $7.49 | $7.49 | $7.49 | $7.49 | 131 | 131 | 100% |
06-27-2024 | $0 | $7.62 | $0 | $0 | 100 | 100 | 100% |
06-26-2024 | $7.76 | $7.62 | $7.76 | $7.61 | 1,250 | 1,250 | 100% |
06-25-2024 | $7.59 | $7.5018 | $7.59 | $7.5018 | 1,593 | 1,093 | 68.61% |
06-24-2024 | $7.72 | $7.62 | $7.73 | $7.62 | 2,165 | 1,965 | 90.76% |
06-21-2024 | $7.35 | $7.35 | $7.35 | $7.35 | 300 | 200 | 66.67% |
06-20-2024 | $6.97 | $7.19 | $7.19 | $6.97 | 606 | 515 | 84.98% |
06-18-2024 | $6.95 | $7.05 | $7.05 | $6.95 | 475 | 475 | 100% |
06-17-2024 | $7.2 | $6.93 | $7.2 | $6.93 | 370 | 370 | 100% |
06-14-2024 | $7.28 | $7 | $7.28 | $7 | 6,876 | 6,876 | 100% |
06-13-2024 | $6.85 | $6.8 | $6.85 | $6.8 | 724 | 624 | 86.19% |
06-11-2024 | $6.69 | $6.69 | $6.69 | $6.69 | 155 | 155 | 100% |
06-07-2024 | $6.69 | $6.69 | $6.69 | $6.69 | 368 | 317 | 86.14% |
News, Short Squeeze, Breakout and More Instantly...
MISSISSAUGA, Ontario, June 12, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its wholly-owned subsidiary, BioSyent Pharma Inc. (“BioSyent Pharma”), has entered into an agreement with a Euro...
MISSISSAUGA, Ontario, May 16, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three months (Q1) ended March 31, 2024. Key highlights include: Return on Equity for TTM March 31, 2024 was 21% as compared to 15% ...
MISSISSAUGA, Ontario, May 16, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.045 per common share, payable in Canadian Dollars on June 15, 20...